REBECCA WIDEL: Open Payments
NPI 1699317743 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 34 payments from 7 companies in 2025. Trend: 2023 $151 · 2024 $284 · 2025 $729
Food & beverage: $620Education: $109
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 10 | $246 |
| Teva Pharmaceuticals USA, Inc. | 11 | $199 |
| Alkermes, Inc. | 8 | $183 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: INGREZZA, ARISTADA, UZEDY, LYBALVI, CAPLYTA, COBENFY, VRAYLAR, INVEGA SUSTENNA.
Industry payments across SC — which companies pay providers there.
